EPPENDORF SE

Company Snapshot

Founded: 1945
Entity Type: Private
Employees: 4,937
Region: Americas
Revenue: $1,169.6 Millions
Revenue Year: 2023
Headquarter: Hamburg, Germany
Key Geographics: Americas, Europe, Asia-Pacific, Africa, China
Corporate Address: Barkhausenweg 1 22339 Hamburg Germany Tel: +49-40-53-801-0 www.eppendorf.com

Company Overview

Eppendorf SE has been manufacturing, developing and marketing premium products, software, and services for use in global research and industrial labs. The firm is a leading player in the worldwide market for laboratory products in the life science sector. Eppendorf focuses on bolstering this leadership by consistently increasing the business and concentrating on cutting-edge, rapidly expanding segments of the life science sectors. With its headquarters located in Hamburg, Germany, the Eppendorf Group currently has production and research facilities across Europe, Asia, and North America. It also has subsidiaries in 33 other countries.

The following industries are served by Eppendorf: consumables, lab solutions, bioprocess, separation & instrumentation, and liquid handling. Our product line includes centrifuges, mixers, dispensers, pipettes and pipetting robots. Eppendorf also sells shakers, fermenters, bioreactors, incubators for CO2, and ultra-low temperature freezers. Microplates, reaction tubes, pipette tips, and single-use bioreactors are examples of consumables that complete the line of premium, top-notch items.

EPPENDORF SE In Reports

Separation Systems for Commercial Biotechnology

According to BCC Research detailed report on Separation Systems for Commercial Biotechnology market report includes global revenue ($ million) for base year data 2024, estimated data for 2025, and forecast data for 2026...

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

BCC Research Market Analyst says global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029

Single-use Technologies for Biopharmaceuticals: Global Markets

BCC Research Market Analyst says global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029 at a CAGR of...

Company's Business Segments

  • Separation and Instrumentation : Centrifuges, Ultra-low-temperature (ULT) freezers, PCR thermal cyclers
  • Liquid Handling : Pipettes and pipetting aids, Pipette manager (connected pipettes), Automated pipetting systems
  • Consumables : Sample tubes, Pipette tips, Multiwell plates
  • Lab Solutions (Bioprocess and Digital) : Bioreactors, Bioprocess control systems, Bioprocess Autosampler

Applications/End User Industries

  • Biotechnology
  • Pharmaceuticals
  • Clinical Diagnostics
  • Academic Research
  • Environmental Testing
  • Food and Beverage
AI: Your Say